Objective: The aim of the study was to compare the effect of two designs of ankle-foot orthosis on people with stroke. Design: The study design was an assessor-blind, multicentre randomized controlled trial. Setting: The setting was community stroke services. Participants: A total of 139 community-dwelling stroke survivors with limited mobility were recruited. Interventions: The two most commonly used types of ankle-foot orthosis (bespoke and off-the-shelf) were chosen.
Introduction
Most stroke survivors' mobility is limited by enduring impairments such as weakness, spasticity and poor balance. 1 Foot drop, due to weak dorsiflexors, is common and contributes to a slow, inefficient gait and high risk of falls. [2] [3] [4] This in turn limits functional mobility, community integration and quality of life for many stroke survivors, many of whom are only able to mobilize independently using an assistive device.
One such device is an ankle-foot orthosis. This is a thermoplastic moulded splint or leg brace that fits inside the user's shoe and up the back of the calf to hold the foot and ankle in the neutral position (Supplementary Figure 1) . Our earlier systematic reviews have shown that an ankle-foot orthosis normalizes the movements of the ankle and knee during swing and stance phase of gait and stabilizes the foot so the user can safely transfer their weight over their foot during stance phase. 5 This has a beneficial effect on mobility, balance, gait and falls risk. 6 However, most trials have used a paired subject design (a randomized comparison with and without the ankle-foot orthosis) and only looked at the immediate effects of the ankle-foot orthosis. The only parallel-group trial of ankle-foot orthoses to date used a control group with no ankle-foot orthosis (n = 28) and reported better gait and mobility at three-month follow-up. 7 This evidence supporting ankle-foot orthoses is recognized in the UK's National Clinical Guidelines for Stroke 8 which recommend an ankle-foot orthosis to improve balance and mobility. It further recommends that the ankle-foot orthosis be individually fitted but this is based on expert opinion as there are no existing studies to inform choice of ankle-foot orthosis.
Therefore, we undertook the first randomized comparison of the two most commonly used types of ankle-foot orthosis: (1) a bespoke, individually fitted ankle-foot orthosis, and (2) an off-the-shelf ankle-foot orthosis. Both can improve walking compared to 'no ankle-foot orthosis'. [5] [6] [7] The bespoke ankle-foot orthosis may fit better but is more expensive and requires more time and resources to fit. Thus, we wished to establish whether differences in their acceptability, safety and effectiveness would justify the current guideline.
Methods
A phase-II, assessor-blind, multicentre randomized controlled trial (RCT) to compare a bespoke versus an off-the-shelf ankle-foot orthosis on short-and long-term satisfaction; adverse events; mobility and gait was undertaken. Recruitment and retention rates were monitored closely to assess the feasibility of a large-scale, phase-III trial. Ethical approval was obtained from the Lancaster Committee of the National Research Ethics Service (reference 11/ NW/0352; International Standard Randomized Controlled Trial Number (ISRCTN) 98287938).
Participants were community-dwelling adult stroke survivors with self-reported limited mobility, impaired dorsiflexion and no contractures at the ankle (following clinical assessment) but who could walk (at least 5 m) without the assistance of another person and give informed written consent. Exclusion criteria were comorbidities that severely limited mobility or precluded use of an ankle-foot orthosis. Stroke survivors who had previously had an anklefoot orthosis but stopped using it and were willing to try again were included. Those who currently used an ankle-foot orthosis were excluded. There were no criteria regarding the participants' age or time since their stroke. They were recruited from the clinical databases of stroke, therapy or rehabilitation services of nine hospitals in England. In addition, potential participants were contacted directly via stroke support groups and research volunteer databases using invitation letters, newsletters, websites, posters in high-traffic areas (such as stroke units and outpatient clinics) and social media outlets (Twitter, Facebook and blogs).
No data were available regarding the variability of the outcome measures in a population using these ankle-foot orthoses to inform sample size calculation. We initially aimed to recruit 75 participants in each group to inform sample size calculation for a phase-III trial and gain sufficient experience of logistics to assess feasibility. Follow-up of this many participants would give 95% probability of identifying an adverse event occurring in 5% or more of participants in each group. For practical reasons and blind to outcome data, we later reduced the target to a minimum of 45 per group providing outcome data.
Potential participants were given a screening letter and information sheet. Suitable participants were visited by a member of the research team to determine eligibility. Once informed consent had been obtained, a referral was made to the participant's local orthotics service. After baseline assessment, the online randomization service was contacted and the orthotist informed of the group allocation. At the appointment, the treating orthotist fitted the ankle-foot orthosis allocated according to their usual clinical practice. All other aspects of the participants' treatment (delivery, fitting and follow-up support) were provided in line with the orthotics services' usual practice.
Randomization was undertaken by an independent telephone randomization service (http://www. sealedenvelope.com) and was stratified according to the participants' functional mobility (household or community walker), 9 whether the participant was receiving outpatient-or community-based rehabilitation, and by sex.
Ankle-foot orthoses
The bespoke ankle-foot orthoses were prescribed, designed and fitted by a qualified orthotist. The orthotists provided the design of ankle-foot orthosis they felt would best meet the patient's needs in line with their usual clinical practice. A typical design of bespoke ankle-foot orthosis is shown in Supplementary Figure 1 . Participants randomized to the off-the-shelf ankle-foot orthosis group were fitted with a light-weight, flexible posterior leaf spring ankle-foot orthosis (Supplementary Figure 1) . We undertook extensive consultations with orthotists and physiotherapists supplying and prescribing ankle-foot orthoses to choose the off-the-shelf orthosis. Our choice was considered the off-the-shelf ankle-foot orthosis of choice by most consultees and was the one most commonly used in clinical practice, as it was thought to be an effective design, of medium price and applicable to a wide range of patients. A bespoke ankle-foot orthosis typically requires two to three visits to the orthotics department for casting, fitting and review, while an off-the-shelf ankle-foot orthosis typically requires only one. Our monitoring of participants' flow through the trial therefore included waiting time for fitting.
Assessments
Assessments were undertaken at baseline, 6 weeks (short-term follow-up) and 12 weeks (long-term follow-up) later by a member of the research team. Where the process to fit and supply the ankle-foot orthosis was so prolonged that it exceeded the assessment period, we followed the pragmatic principle of intention to treat. In these cases, assessments were completed without the ankle-foot orthoses as patient satisfaction with the ankle-foot orthosis (or lack of it) and prevention of adverse events (such as falls) were important outcomes.
It was not possible to blind participants to the intervention received. Blinded assessment was maintained as far as possible by asking participants to wear trousers and a sock over the ankle-foot orthosis during assessments to conceal the type of orthosis from the assessors. Participants were also requested not to discuss or reveal their type of ankle-foot orthosis with the assessor.
Outcome measures
Our primary outcome measure was long-term satisfaction with the ankle-foot orthosis assessed using the Patient Satisfaction Questionnaire previously developed and used by Tyson and Thornton 10 (Online Appendix 1). This outcome measure was chosen as it is well established that an ankle-foot orthosis can improve gait and mobility; 5, 6 however, if the patient is not satisfied with the ankle-foot orthosis and does not wear it, then it will not be effective whatever its potential impact on gait.
Secondary outcomes were as follows: Analyses of recruitment, retention and adverse events were descriptive, citing number and percentage in each case. Clinical outcomes were compared on both an intention-to-treat and per-treatment basis. Outcome data for all participants were sought regardless of treatment adherence unless consent to follow-up was explicitly withdrawn. Regression analyses controlled for the stratification factors and, where available, baseline measures of the outcome variable. We used multiple logistic regression to give an odds ratio (95% confidence interval (CI)) for binary outcomes and linear regression to give a mean difference (95% CI) for continuous outcomes. Thematic content analysis was used to analyse the responses to open questions in the satisfaction questionnaire. 13 
Results
A total of 139 participants were recruited. In the first six months, recruitment averaged three participants per month, rising to nine per month in the final six months as our strategy developed. The most successful recruitment strategy was to approach current and former patients of stroke, therapy and rehabilitation services directly by post (Figure 1) .
Patient flow through the trial is detailed in Figure  1 . Retention rates were high. Most participants were fitted with the ankle-foot orthosis to which they were randomized. However, of those randomized to receive an off-the shelf ankle-foot orthosis, • • Two were supplied with a bespoke ankle-foot orthosis because they could not fit into an offthe-shelf orthosis due to high muscle tone (n = 1) or limited dorsiflexion range (n = 1);
• • For the other four participants, no explanation was given; • • Two were given a different design of off-theshelf ankle-foot orthosis: a metal leg iron/ caliper; • • Seven were not given an ankle-foot orthosis as the orthotist considered it unnecessary.
Of those randomized to receive a bespoke ankle-foot orthosis, • • Sixteen were supplied with an off-the-shelf ankle-foot orthosis because the orthotist considered a bespoke orthosis was too expensive (n = 1) or too restrictive of range of movement at the ankle (n = 4). Five were fitted in error and no explanation was given for the remaining six. • • Five were not given an orthosis as the orthotist considered it unnecessary.
Participants' characteristics and baseline measures are detailed in Table 1 . Age ranged 24-93 years and 99 (71%) were male. Most (64%) were 'community walkers'. There were no marked differences between groups at baseline. At short-term assessment, 94 (68%) participants had received their ankle-foot orthosis, 40 (58%) in the bespoke orthosis group and 54 (77%) in the off-the-shelf orthosis group.
Sixty-five percent (n = 26) of respondents from the bespoke group and 61% (n = 33) of off-theshelf group were satisfied or very satisfied with their ankle-foot orthosis: OR (95% CI) = 1.3 (0.62 to 2.9); P = 0.47. By the long-term assessment, the corresponding figures were 72% and 64%, respectively: OR (95% CI) = 0.64 (0.31 to 1.3); P = 0.21 (Table 2) . Classifying by treatment received, satisfaction scores were 64% versus 61% at short-term and 72% versus 63% at long-term follow-up, both in favour of off-the-shelf ankle-foot orthosis.
Questions of comfort and convenience are reported in Table 3 . We did not statistically compare these secondary outcomes, but all observed differences favoured the off-the-shelf ankle-foot orthosis. Responses did not change materially between shortterm and long-term follow-ups. Analysis of the open questions in the satisfaction questionnaire indicated that participants felt the main benefit of an orthosis was that it improved their walking by improving the alignment of their foot and ankle. It stopped their foot turning over (inversion), enabled them to put their foot down first (heel strike) safely and gave them confidence that they would not trip. The offthe-shelf ankle-foot orthosis group more frequently reported a beneficial effect on foot posture and alignment (n = 38 versus 17).
Sixty-four orthosis-related adverse events were reported and are detailed in Table 4 . The most serious adverse events, a head injury and a fractured neck of femur following a fall, both occurred while the participant was waiting for their ankle-foot orthosis be fitted. Of the remaining falls causing severe events, only one participant was wearing their orthosis at the time. Of the falls causing moderate adverse events, all occurred while the participant was active (e.g. negotiating stairs, walking on a moving train or attending a football match). Half occurred while they were wearing the orthosis and three while awaiting receipt of the orthosis. Of the falls causing mild adverse events, 12 occurred while the participant was wearing the orthosis and 4 while waiting for the orthosis to be fitted. In total, 10 participants (5 in each group) reported abandoning their orthosis because of adverse events. We did not statistically compare the number of adverse events between groups. Both groups improved in all measures of clinical effectiveness between baseline and both short-term and long-term follow-ups. There were no substantive differences between allocated groups in functional mobility, gait speed, step length or longer-term falls efficacy (Table 5) . At short-term follow-up, fear of falling was significantly lower in the off-the-shelf ankle-foot orthosis group: mean difference (95% CI) = −4.6 (−7.6 to −1.6); P = 0.003. Conclusions were not materially altered when comparing groups according to treatment as received.
Discussion
This is the first RCT to compare the effects of different types of ankle-foot orthosis. We found that Table 2 . Participants' satisfaction with their ankle-foot orthosis at long-term (primary outcome) and short-term follow-up assessments. 16  25  41  16  17  33  Satisfied  16  16  32  10  16  26  Neutral  6  2  8  3  7  10  Unsatisfied  8  6  14  6  5  11  Very unsatisfied 4  8  12  5  9  14 AFO, ankle-foot orthosis. both groups' mobility, gait and fear of falling improved compared to baseline at both short-term and long-term follow-ups. This concurs with previous reports. 5 However, we did not find any benefits of a bespoke ankle-foot orthosis over off-the-shelf ankle-foot orthosis in terms of patient satisfaction, adverse events or clinical effects. Although most participants were satisfied with their ankle-foot orthosis, the rate of reported difficulties is of concern. Approximately 50% of participants had a problem of some description with their orthosis, many of which were considered serious. Discomfort, skin problems, difficulty getting the ankle-foot orthosis on and off, and fitting it in their shoes were common complaints. There are no accepted minimal levels of satisfaction for healthcare interventions, but these levels are clearly unacceptable. Further research is needed to develop more comfortable, better fitting and convenient designs of anklefoot orthosis.
One of the aims of this trial was to ascertain whether further trials were feasible or necessary. Given that we did not have a sample size calculation (as no previous data existed), one explanation for the lack of difference between groups may be that the trial was under-powered. Using the data from this trial indicates that a sample size of at 
P-value
Short-term follow-up ( least 1300 would be needed for a phase-III trial of clinical effectiveness where functional mobility (Walking Handicap Scale 9 ) was the primary outcome for 80% power to detect a large effect size (OR = 0.75). The timescale and cost of such a phase-III trial is likely to be prohibitive, given the relatively low cost of the interventions. If a future trial design focused on efficacy, then gait speed could be considered as the primary outcome, the minimal clinically important difference of which is 0.2 m/s. 9 Our trial has already excluded a difference of even half of this magnitude in either direction when analysed by either 'intention to treat' or 'treatment as received'. We therefore believe there is little chance of demonstrating a clinical benefit of bespoke ankle-foot orthosis use in this population.
The main limitation of this trial is that the outcome assessors successfully identified the type of ankle-foot orthosis with which most participants had been fitted. It is difficult to know what further measures we could have taken to blind the assessors. Rather, we feel that like many complex interventions, it is not possible to effectively blind assessors, and the risk of bias this presents needs to be accepted as inevitable in this type of intervention.
The high number of allocation deviations may be considered a limitation, but we completed the analyses on the basis of intention-to-treat and pertreatment, and found no difference in the outcomes. Thus, it appears that the deviations did not affect the findings or conclusions of the trial.
A bespoke ankle-foot orthosis costs three to five times more than an off-the-shelf one and requires additional resource to fit. There is an obvious costadvantage to an off-the-shelf orthosis with no evidence to support the more expensive option. If anything, there may be an advantage to the off-theshelf orthosis as they are quicker to provide and thus reduces risk of falls more quickly. The imperative to fit ankle-foot orthosis speedily was starkly illustrated by the two most serious adverse events (head injury and fractured neck of femur) which occurred while awaiting fitting.
We recommend that unless contra-indicated, stroke survivors with limited mobility (plus dorsiflexor weakness and a plantargrade position) should be offered a light-weight, flexible off-theshelf ankle-foot orthosis such as the one used in this trial in the first instance. A bespoke ankle-foot orthosis should be considered if an off-the shelf one proves unsuccessful. It is important to note that this recommendation refers to the type of light-weight, flexible off-the-shelf ankle-foot orthosis used in this trial. It cannot be assumed that all off-the-shelf ankle-foot orthoses will be similarly effective or safe. It is incumbent on manufacturers of the more expensive, bespoke ankle-foot orthoses to demonstrate sufficient clinical superiority of their product to justify the increased waiting time and costs.
Clinical Messages
• • Mobility, gait and fear of falling improved with both a bespoke and an off-the-self orthosis. • • There were no differences between orthoses. • • Problems with the orthosis were common including falls, skin breakdown/rubbing and discomfort. The more severe adverse events happened while waiting for the orthosis to be fitted.
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